Skip to search formSkip to main contentSkip to account menu

ABT 491

Known as: ABT-491 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ImidazolesIndoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Effets de l’ABT-491, un antagoniste du platelet activating factor, en association avec l’adrénaline sur un modèle de choc anaphylactique à l’ovalbumine
2011
2011
Protective Effects of Platelet-Activating Factor Antagonist ABT-491 on the Peripheral Nerves in Hypoxic Ischemia-Induced Neonatal Rat Model
ABS TRACT Ob jec ti ve: Ne o na tal hypo xic-isc he mic (HI) in sult has acu te and long term de le te ri o us ef fects on many… 
2010
2010
Hipoksik iskemik beyin hasar› oluflturulan yenidoan s›çanlarda ABT-491 uygulamas›n›n görsel uyar›lma potansiyelleri üzerine etkileri The effects of ABT-491 administration on visual evoked potentials…
C›kar›mlar: Hipoksik iskemik beyin hasar›n›n GUP yan›tlar›n›n genliklerinde azalmaya neden olduu ve bu azalman›n ABT-491 ile… 
2003
2003
ABT-491 : A potent and selective PAF receptor antagonist First available from Sigma-RBI ! New PPAR Products
  • 2003
  • Corpus ID: 157063518
Intense interest exists in the biology of platelet-activating factor (PAF; Prod. No. P 7568), a diacylphosphatidylcholine [1… 
1997
1997
ABT-491, a highly potent and selective PAF antagonist, inhibits nasal vascular permeability associated with experimental allergic rhinitis in Brown Norway rats
Allergic rhinitis is an inflammatory disease of the upper airway. Symptoms of the disease, which include congestion, rhinorrhea… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)